Autopsy report · NCT01955733

Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis

“Substance discontinued”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months after it had already started.
• Ran for about 3 years 5 months before it stopped.
• 91 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Boehringer Ingelheim

Sponsor type

Industry

Conditions

Arthritis, Rheumatoid

Interventions

BI 695500

Participants

91

Sites

43

Countries

Belgium, Bulgaria, Germany, Greece, Netherlands, Poland, Portugal, Spain, United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.